These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 3029769

  • 1. A promoterless retroviral vector indicates that there are sequences in U3 required for 3' RNA processing.
    Dougherty JP, Temin HM.
    Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1197-201. PubMed ID: 3029769
    [Abstract] [Full Text] [Related]

  • 2. Retroviral vectors produced in the cytoplasmic vaccinia virus system transduce intron-containing genes.
    Konetschny C, Holzer GW, Falkner FG.
    J Virol; 2002 Feb; 76(3):1236-43. PubMed ID: 11773399
    [Abstract] [Full Text] [Related]

  • 3. Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors.
    Schambach A, Galla M, Maetzig T, Loew R, Baum C.
    Mol Ther; 2007 Jun; 15(6):1167-73. PubMed ID: 17406345
    [Abstract] [Full Text] [Related]

  • 4. The U3 region is not necessary for 3' end formation of spleen necrosis virus RNA.
    Iwasaki K, Temin HM.
    J Virol; 1990 Dec; 64(12):6329-34. PubMed ID: 1700836
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Unusually high frequency of reconstitution of long terminal repeats in U3-minus retrovirus vectors by DNA recombination or gene conversion.
    Olson P, Temin HM, Dornburg R.
    J Virol; 1992 Mar; 66(3):1336-43. PubMed ID: 1310753
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
    Robinson D, Elliott JF, Chang LJ.
    Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reconstituting retroviral (ReCon) vectors facilitating delivery of cytotoxic genes in cancer gene therapy approaches.
    Brandtner EM, Kodajova P, Hlavaty J, Jandl G, Tabotta W, Salmons B, Günzburg WH, Hohenadl C.
    J Gene Med; 2008 Feb; 10(2):113-22. PubMed ID: 18076132
    [Abstract] [Full Text] [Related]

  • 15. Template switching by RNA polymerase II in vivo. Evidence and implications from a retroviral system.
    Kandel ES, Nudler E.
    Mol Cell; 2002 Dec; 10(6):1495-502. PubMed ID: 12504023
    [Abstract] [Full Text] [Related]

  • 16. An improved retroviral vector for assaying promoter activity. Analysis of promoter interference in pIP211 vector.
    Nakajima K, Ikenaka K, Nakahira K, Morita N, Mikoshiba K.
    FEBS Lett; 1993 Jan 04; 315(2):129-33. PubMed ID: 8417968
    [Abstract] [Full Text] [Related]

  • 17. Co-packaging of non-vector RNAs generates replication-defective retroviral vector particles: a novel approach for blocking retrovirus replication.
    Joshi S, Ding SF, Liem SE.
    Nucleic Acids Res; 1997 Aug 15; 25(16):3199-203. PubMed ID: 9241231
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Genetic reshuffling reconstitutes functional expression cassettes in retroviral vectors.
    Tabotta W, Klein D, Hohenadl C, Salmons B, Günzburg WH.
    J Gene Med; 2001 Aug 15; 3(5):418-26. PubMed ID: 11601755
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.